The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy Virtual 2020 | Immunotherapy for myeloma: past, present, future
Hermann Einsele, MD, FRCP, University of Würzburg, Würzburg, Germany, discusses the use of immunomodulatory therapies in multiple myeloma (MM), including monoclonal antibodies and checkpoint inhibitors. Prof. Einsele gives us an overview of the progress that has been made in the treatment of MM, as well as looking towards the future of immunotherapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
